PMID- 35461286 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2045-3701 (Print) IS - 2045-3701 (Electronic) IS - 2045-3701 (Linking) VI - 12 IP - 1 DP - 2022 Apr 23 TI - Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation. PG - 46 LID - 10.1186/s13578-022-00780-z [doi] LID - 46 AB - BACKGROUND: Intestinal immune dysfunction is involved in the onset of Crohn's disease (CD). Dendritic cells (DCs), antigen-presenting cells, play a key role in the maintenance of intestinal immune homeostasis. The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor widely expressed in various immune cells, including DCs. Although AhR plays an important role in immune tolerance, its role in the DCs is unclear. The purpose of this study was to investigate whether the activation of AhR can induce tolerogenic DCs (tolDCs) and the differentiation of regulatory T (Treg) cells, as well as ameliorate experimental colitis. RESULTS: AhR activation in the DCs resulted in a lower expression of surface markers such as CD80, CD83, CD86, and pro-inflammatory cytokine production, and higher anti-inflammatory production (IL-1beta, IL-23, and IL-12) compared to the control DCs. The surface dendrites in DCs were significantly reduced following AhR activation by 6-formylindolo [3,2-b]carbazole (FICZ). Such DCs with FICZ-mediated activation of AhR, namely tolDCs, promoted Treg cell differentiation. Adoptive transfer of tolDCs to a TNBS-induced colitis mouse model significantly alleviated the severity of inflammation by improving the colon length and decreasing the disease activity index (DAI) and histopathological score. Moreover, the transferred tolDCs decreased the frequency of Th17 cells and increased the frequency of Treg cells in the spleen and mesenteric lymph nodes (MLNs) in murine colitis models. CONCLUSIONS: Activation of AhR in the DCs could induce tolDCs, and the transplantation of tolDCs may help in relieving intestinal inflammation and maintaining the Th17/Treg differentiation balance. Thus, our data suggest that AhR may be a potential therapeutic target for CD. CI - (c) 2022. The Author(s). FAU - Cui, Xiufang AU - Cui X AD - Department of Gastroenterology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China. AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Ye, Ziping AU - Ye Z AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Wang, Di AU - Wang D AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Yang, Yan AU - Yang Y AD - Department of Gastroenterology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211100, Jiangsu, People's Republic of China. FAU - Jiao, ChunHua AU - Jiao C AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Ma, Jingjing AU - Ma J AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Tang, Nana AU - Tang N AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. FAU - Zhang, Hongjie AU - Zhang H AUID- ORCID: 0000-0003-4497-0503 AD - Department of Gastroenterology, First Affiliated Hospital of Nanjing Medical University, 300# Guangzhou Road, Nanjing, 210029, Jiangsu, People's Republic of China. hjzhang06@163.com. LA - eng GR - 82070568/National Natural Science Foundation of China/ GR - 81770553/National Natural Science Foundation of China/ GR - JX10213640/Postgraduate Research & Practice Innovation Program of Jiangsu Province/ PT - Journal Article DEP - 20220423 PL - England TA - Cell Biosci JT - Cell & bioscience JID - 101561195 PMC - PMC9034494 OTO - NOTNLM OT - Aryl hydrocarbon receptor OT - Crohn's disease OT - Dendritic cells OT - Intestinal immune tolerance OT - Treg cells COIS- The authors declare that they have no conflict of interest. EDAT- 2022/04/25 06:00 MHDA- 2022/04/25 06:01 PMCR- 2022/04/23 CRDT- 2022/04/24 20:05 PHST- 2020/09/09 00:00 [received] PHST- 2022/03/30 00:00 [accepted] PHST- 2022/04/24 20:05 [entrez] PHST- 2022/04/25 06:00 [pubmed] PHST- 2022/04/25 06:01 [medline] PHST- 2022/04/23 00:00 [pmc-release] AID - 10.1186/s13578-022-00780-z [pii] AID - 780 [pii] AID - 10.1186/s13578-022-00780-z [doi] PST - epublish SO - Cell Biosci. 2022 Apr 23;12(1):46. doi: 10.1186/s13578-022-00780-z.